Text Size

Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sjögren syndrome dry eye patients

Liang H., Kessal K., Rabut G., Daull P., Garrigue J.S., Melik Parsadaniantz S., Docquier M., Baudouin C., Brignole-Baudouin F.


  • 2019
  • Ocular Surface
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Affiliations

    Sorbonne Universités, UPMC Univ Paris 06, INSERM, CNRS, Institut de la Vision, Paris, France; Quinze-Vingts National Ophthalmology Hospital, DHU Sight Restore, INSERM-DHOS CIC1423, Paris, France; Santen SAS, Evry, France; iGE3 Genomics Platform University of Geneva, Geneva, Switzerland; Université Versailles-Saint-Quentin-en-Yvelines, UVSQ, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France; Université Sorbonne Paris Cité USPC, Université Paris Descartes, Faculté de Pharmacie de Paris, France

Related Publications

Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study

Ishikawa H., Oka K., Inoue H.


Tear Biomarkers of Topical Sirolimus in Meibomian Gland Dysfunction: A Randomized Trial

Zhou L.; Shimizu H.; Togashi Y.; Kirihara T.; Yang Y.; Lam C.T.; Shimada H.; Tong L.


Layer-by-layer tear film measurement in patients with dry eye and meibomian gland dysfunction

Arita R., Takeuchi G., Sasai K., Nakamura M., Akiba M.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022